Posts from ‘October, 2008’

NATICK, Mass., Oct. 29 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) today welcomed passage of legislation to help active members of the U.S. armed forces and service veterans better manage the challenges of chronic pain.

The Military …
Devices
Boston Scientific

EATONTOWN, N.J., Oct. 29 (HSMN NewsFeed) — Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic solutions for regenerative healing, announced today that it has received 510(k) clearance from the United States Food and Drug Adminis…
Devices, FDA
Osteotech, OsteoBiologic, bone graft substitute

SKILLMAN, N.J., Oct. 29 (HSMN NewsFeed) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced that Michael E. Steadman will join ConvaTec as President of the company’s Woun…
Devices, Wound Care, Personnel
ConvaTec

EMD Serono to acquire US rights in tesamorelin, a Phase III compound being investigated for the treatment of excess abdominal fat in HIV patients with lipodystrophy

Theratechnologies to receive up to US$215 million plus increasing royalties on net sales…
Biopharmaceuticals, Licensing
EMD Serono, Merck KGaA, Theratechnologies, tesamorelin, lipodystrophy

ERBITUX Receives Additional Approval from Health Canada for the First-Line Treatment of Head and Neck Cancer

NEW YORK–(HSMN NewsFeed)–ImClone Systems Incorporated (NASDAQ: IMCL ) today announced the commercial launch of ERBITUX® (cetuximab) in Can…
Biopharmaceuticals, Oncology
ImClone Systems, Bristol-Myers Squibb, ERBITUX, cetuximab, mCRC

Complaint Alleges Defamation, Trade Libel and Intentional Interference with Prospective Business Advantage

CAMBRIDGE, Mass., Oct. 28 (HSMN NewsFeed) — Biopure Corporation (Nasdaq: BPUR ) announced today that it had filed an action for injunctive reli…
Biopharmaceuticals
Biopure, Hemopure, blood substitute, HBOC-201

CAMBRIDGE, Mass., Oct. 28, 2008 — (HSMN NewsFeed) — Infinity Pharmaceuticals, Inc. (NasdaqGM:INFI ), an innovative cancer drug discovery and development company, today announced the promotion of Adelene Q. Perkins to president and chief business officer….
Biopharmaceuticals, Personnel
Infinity Pharmaceuticals

New Device Designed to Minimize Discomfort and Pain Following Ostomy Surgery

SKILLMAN, N.J., Oct. 28 (HSMN NewsFeed) — ConvaTec, a world-leading manufacturer of ostomy and wound care products, announced today the launch of SUR-FIT Natura® Low-Pre…
Devices, Wound Care
ConvaTec, SUR-FIT Natura , ostomy

IRVINE, Calif.–(HSMN NewsFeed)–Pegasus Biologics, Inc. a privately held developer of collagen scaffolds for soft tissue repair and wound care management, announced today that it has named Rob Cripe Vice President of Marketing and Product Development. Cri…
Devices, Personnel
Pegasus Biologics

First Prospective Two-Year Safety and Efficacy Data to be Presented for an ERA Therapy in PAH

PHILADELPHIA–(HSMN NewsFeed)–Gilead Sciences, Inc. (Nasdaq:GILD ) today announced results of a two-year (104-week), open-label, uncontrolled, extension study…
Biopharmaceuticals
Gilead Sciences, ARIES-E, Letairis, ambrisentan, pulmonary arterial hypertension